BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 13, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory front for June 16, 2020

June 16, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Endologix, Klarity, Supernus, United Therapeutics.
Read More

Regulatory actions for June 16, 2020

June 16, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clew, Guard Medical, Infinity, Inmode, Smith+Nephew.
Read More

In the clinic for June 16, 2020

June 16, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Exact Sciences, Halo Diagnostics, Lucence, Medtronic, Sequana Medical.
Read More

Etherna closes $38M series B round for mRNA vaccine push in COVID-19, cancer

June 16, 2020
By Cormac Sheridan
DUBLIN – Etherna Immunotherapies NV raised €34 million (US$38.2 million) in a series B funding round to progress its pipeline of mRNA-based vaccines for cancer and infectious disease.
Read More
Coronavirus, lungs

Dexamethasone shows benefit in treating COVID-19 in Recovery trial

June 16, 2020
By Nuala Moran
LONDON – In the first major breakthrough in therapeutics for COVID-19 infection, dexamethasone has been shown to have a statistically significant impact on mortality in the most seriously ill patients.
Read More
Argentinian flag

Argentina researchers pitting camelid-based antibody strategy against SARS-CoV-2

June 16, 2020
By Sergio Held
CAJICA, Colombia – A team of scientists in Argentina is working on obtaining monoclonal antibodies from hens and llamas in a bid to produce both a vaccine and a drug for SARS-CoV-2, but the development process is highlighting the challenges that researchers and scientists in developing countries with troubled economies can face.
Read More

Regulatory actions for June 16, 2020

June 16, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akili, Arch, Edesa, Eli Lilly, Jazz, Valeo.
Read More

Other news to note for June 16, 2020

June 16, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Agex, Aldevron, Amyndas, Annovis, Astrazeneca, Cascade, Cobra, Forte, Genprex, Hoth, Ichor, Immunomic, Kalytera, Lead Discovery Center, Matrix, QLi5, Qurient, Moleculin, Monopar, Northstar, Olix, Peptc Vaccines, PJSC Pharmsynthez, Pluristyx, Quartesian, Renibus, Salzman, Sanofi, Tocagen, Treos, Vyripharm, Xenetic.
Read More

In the clinic for June 16, 2020

June 16, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Amarin, Anavex, Arecor, Bionic Sight, Dermavant, Enb, Exicure, Forma, Humanigen, Immunicum, Janssen, Merck, Neuren, Oncopeptides, PDS, Pfizer, Provention, Renibus, Sanofi, Sarepta, Vyome.
Read More

Regulatory front for June 16, 2020

June 16, 2020
The latest global regulatory news, changes and updates affecting biopharma, including: Amgen, Esperion, Gilead, Lilly, Merck, Novartis.
Read More
Previous 1 2 … 434 435 436 437 438 439 440 441 442 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

    BioWorld Science
    Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing